Müller, Norbert <br/><br/>
COX-2 inhibition in schizophrenia and major depression.  [electronic resource] 

 -  Current pharmaceutical design  2008 
 - 1452-65 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1873-4286 
<br/><br/><label>Standard No.: </label>10.2174/138161208784480243  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cyclooxygenase 2--biosynthesis<br/>Cyclooxygenase 2 Inhibitors--therapeutic use<br/>Cytokines--metabolism<br/>Depressive Disorder, Major--immunology<br/>Electroconvulsive Therapy<br/>Humans<br/>Hypothalamo-Hypophyseal System--physiopathology<br/>Inflammation--immunology<br/>Kynurenic Acid--metabolism<br/>Pituitary-Adrenal System--physiopathology<br/>Receptors, N-Methyl-D-Aspartate--agonists<br/>Schizophrenia--immunology<br/>Sleep Deprivation<br/>Synaptic Transmission